Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria | MicrobiomeTrials← Back to trialsNCT05750459
Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2023-11-29Est. Completion: 2025-04-01
Enrollment target: 90 participants Locations- Makerere University-Infectious Diseases Institute, Kampala, Uganda
Other microbiome trials you might be interested in
Vivax MalariaG6PD Deficiency
Significant gains have been made in reducing the overall burden of malaria worldwide, however these have been far greate…
Kokopo, Papua New GuineaCompleted Oct 25, 2025
Falciparum; Malaria
A prospective study will be carried out in an area where parasites with reduced sensitivity to malaria drugs (artemisini…
Kalongo, UgandaCompleted Nov 22, 2025